The story so far..............
The pharmacist locks the patient into one pharmacy (likely to be a large
high tech national group, not my local rural chemist).
Repeat prescriptions are generated regardless of whether the patient
asks for them. OK for Ramipril, potentially big profits for PRN drugs
that the patient doesn't need automatically each month.
The pharmaceutical companies can buy into a database detailing
individual doctors prescribing habits.
I am sure there must be a downside to this somewhere. Perhaps someone
can let me know.
--
Paul J Scott, Primary Care Physician, United Kingdom.
Fax 44 (0)1935 410188
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|